10% Reverse Micelle VC
10% Reverse Micelle VC
10% L‑Ascorbic Acid (reduced form), nano-reverse micelle encapsulation system; enhances VC stability and transdermal absorption rate, reduces irritation of VC
Product overview
Derived from South American acerola cherry. Every 100 g contains an ultra-high 4000 mg vitamin C, widely recognized worldwide as the "King of Natural VC". It also contains multiple nutrients including vitamin A, B1, B2, E and P. Nanoscale reverse micelle technology greatly improves its stability, reduces fission-type deactivation and markedly enhances transdermal absorption efficiency of the ingredient. Replace oxidation concerns with radiant confidence; deliver nature-powered whitening, antioxidant and skin-renewing potency intact to your skin
Composition Information
| Component Type | INCI | CAS | EC |
|---|---|---|---|
| Components | ASCORBIC ACID | 50-81-7 / 62624-30-0 | 200-066-2 / 263-644-3 |
| Components | GLUCOSYLRUTIN | 130603-71-3 | |
| Components | GLYCYRRHIZA URALENSIS (LICORICE) EXTRACT | ||
| Components | PERILLA FRUTESCENS EXTRACT | 90082-61-4 | 290-151-0 |
| Components | AVENA SATIVA KERNEL EXTRACT | 84012-26-0 | 281-672-4 |
| Components | OROXYLUM INDICUM SEED EXTRACT | ||
| Components | SECALE CEREALE SEED EXTRACT | 90106-48-2 | 290-271-3 |
| Components | BISABOLOL | 515-69-5 / 23089-26-1 | 208-205-9 / 245-423-3 |
| Components | SWEET ALMOND OIL PEG-8 ESTERS | ||
| Components | BUTYLENE GLYCOL | 93763-20-3 | 297-837-9 |
| Components | DIMETHYL ISOSORBIDE | 5306-85-4 | 226-159-8 |
| Components | PPG-20 METHYL GLUCOSE ETHER | 61849-72-7 | |
| Components | RUBUS FRUTICOSUS FRUIT EXTRACT | 84787-69-9 | 284-110-6 |
| Components | PEG-12 DIMETHICONE CROSSPOLYMER | ||
| Components | CITRUS SINENSIS FRUIT EXTRACT | 8028-48-6 | 232-433-8 |
| Components | POLYGLYCERYL-2 DIPOLYHYDROXYSTEARATE | 144470-58-6 | |
| Components | POLYGLYCERYL-4 DIISOSTEARATE/POLYHYDROXYSTEARATE/SEBACATE | ||
| Components | DIPENTAERYTHRITYL TETRAISOSTEARATE | 62125-22-8 | 263-423-1 |
| Components | OLIVE OIL DECYL ESTERS |
Literature & Patents
Developed by Professor Hu Chunqiu’s team. It is a highly stable vitamin C composition for skin brightening and anti-aging cosmetic applications.
Patent No.: ZL202511586276.7
Mechanism of Action
1. Skin-brightening pathway: Inhibit tyrosinase activity, reduce pigment formation and lower intracellular pigment content.
2. Anti-aging & collagen-promoting pathway: As a cofactor for key enzymes in collagen synthesis, it upregulates mRNA expression of type Ⅰ and type Ⅳ collagen. Meanwhile, it inhibits elastase to slow down collagen degradation.
3. Antioxidant pathway: Directly bind reactive oxygen free radicals to form dehydroascorbic acid, and rely on the GSH system for cyclic reduction to continuously scavenge free radicals.
4. Soothing & repairing pathway: Regulate multiple immune-related components and inflammatory proteins, downregulate the levels of inflammatory factors including PCT, TNF‑α, IL‑6 and IL‑8, and promote epidermal repair.
5. Delivery mechanism: Reverse micelle nano-aggregates act as carriers. Encapsulated native VC penetrates the skin barrier and is released to exert effects.
Experimental Data
1. Anti-aging – elastase inhibition test: 10% VC achieves 81.39% inhibition rate against elastase.
2. Anti-aging – fibroblast collagen expression test: After VC treatment, type Ⅰ collagen mRNA expression is up-regulated up to 2.4 times; type Ⅳ collagen mRNA expression is up-regulated up to 3.1 times.
3. Repair – nematode wound repair test: The VC group shows 85% higher wound repair efficiency compared with model group.
4. Brightening – B16 cellular melanin inhibition test: 10% VC reduces cellular melanin content by approximately 81.7%.
5. Brightening – tyrosinase activity inhibition test: 10% VC reduces tyrosinase activity by approximately 89.3%.
6. Antioxidant free radical scavenging test: At 0.005% VC, hydroxyl radical scavenging rate 93.2%; superoxide anion radical scavenging rate 94.2%; DPPH free radical scavenging rate 93.24%.
7. Anti-inflammatory factor inhibition test: VC downregulates multiple inflammatory markers including PCT, TNF‑α, IL‑6 and IL‑8.
Product specifications
| INCI Name: | ASCORBIC ACID, GLUCOSYLRUTIN, GLYCYRRHIZA URALENSIS (LICORICE) EXTRACT, PERILLA FRUTESCENS EXTRACT, AVENA SATIVA KERNEL EXTRACT, OROXYLUM INDICUM SEED EXTRACT, SECALE CEREALE SEED EXTRACT, BISABOLOL, SWEET ALMOND OIL PEG-8 ESTERS, BUTYLENE GLYCOL, DIMETHYL ISOSORBIDE, PPG-20 METHYL GLUCOSE ETHER, RUBUS FRUTICOSUS FRUIT EXTRACT, PEG-12 DIMETHICONE CROSSPOLYMER, CITRUS SINENSIS FRUIT EXTRACT, POLYGLYCERYL-2 DIPOLYHYDROXYSTEARATE, POLYGLYCERYL-4 DIISOSTEARATE/POLYHYDROXYSTEARATE/SEBACATE, DIPENTAERYTHRITYL TETRAISOSTEARATE, OLIVE OIL DECYL ESTERS |
|---|---|
| Source: | Nano reverse micelle encapsulation technology is adopted. It refers to the natural protective mechanism of vitamin C in prickly pear, where VC is synergistically protected by flavonoids and SOD. |
Key benefits
1. Improved stability: nano-reverse micelle encapsulation reduces oxidative degradation and deactivation of raw L‑ascorbic acid.
2. Enhanced transdermal absorption: the nano structure of reverse micelles improves transdermal absorption efficiency of VC.
3. Reduced irritation: the encapsulation system buffers skin irritation caused by raw L‑ascorbic acid.
4. Multi-effect synergy: multi-dimensional benefits including whitening, antioxidant activity, anti-aging & collagen synthesis promotion, anti-inflammation and repair.
Reliable B2B supply
Supporting Documents
- CISAR: Full Cosmetic Safety Assessment Report
- PPT: Complete Product Introduction Presentation
- FCRM: Full Raw Material Composition Report
- MFC: Manufacturing Process Flow Chart
- MSDS: Material Safety Data Sheet
- SP: Product Specification Sheet
- TDS: Technical Data Sheet
- RMI: Raw Material Information Package
